Ingenol mebutate 0·015% gel is safe for short-term treatment of actinic keratoses on the face in solid organ transplant recipients

Br J Dermatol. 2020 Sep;183(3):575-577. doi: 10.1111/bjd.19050. Epub 2020 May 26.

L D Crow¹, J T Yuan¹, C S Aroyan¹, A R Twigg¹, J P Singer², G R Roll³, A A Lazar^{4

5}, S T Arron¹

¹ Department of Dermatology, University of California San Francisco, San Francisco, CA, USA.
² Department of Medicine, University of California San Francisco, San Francisco, CA, USA.
³ Department of Surgery, Division of Transplant, University of California San Francisco, San Francisco, CA, USA.
⁴ Department of Preventive and Restorative Dental Sciences, University of California San Francisco, San Francisco, CA, USA.
⁵ Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA.

No abstract available

Publication types